US drug watchdog orders new safety warnings for weight-loss drugs over potential risk of vision loss
The US Food and Drug Administration (FDA) is requiring manufacturers of GLP-1 medicines to update their safety labels to warn of a potential increased risk of a rare but serious eye condition that can cause permanent vision loss.
We haven't written up this one. Euronews has the full story — the link below goes straight to it.